Annual Accounts Payable
$6.55 M
-$335.00 K-4.87%
31 December 2023
Summary:
Crinetics Pharmaceuticals annual accounts payable is currently $6.55 million, with the most recent change of -$335.00 thousand (-4.87%) on 31 December 2023. During the last 3 years, it has risen by +$3.13 million (+91.35%). CRNX annual accounts payable is now -4.87% below its all-time high of $6.88 million, reached on 31 December 2022.CRNX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$4.94 M
-$3.93 M-44.33%
30 September 2024
Summary:
Crinetics Pharmaceuticals quarterly accounts payable is currently $4.94 million, with the most recent change of -$3.93 million (-44.33%) on 30 September 2024. Over the past year, it has dropped by -$1.61 million (-24.57%). CRNX quarterly accounts payable is now -59.30% below its all-time high of $12.13 million, reached on 31 March 2022.CRNX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRNX Accounts Payable Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | -24.6% |
3 y3 years | +91.3% | +44.3% |
5 y5 years | +142.7% | +83.1% |
CRNX Accounts Payable High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -4.9% | +91.3% | -59.3% | +44.3% |
5 y | 5 years | -4.9% | +142.7% | -59.3% | +83.1% |
alltime | all time | -4.9% | +1825.9% | -59.3% | +1125.6% |
Crinetics Pharmaceuticals Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $4.94 M(-44.3%) |
June 2024 | - | $8.87 M(-17.5%) |
Mar 2024 | - | $10.76 M(+64.3%) |
Dec 2023 | $6.55 M(-4.9%) | $6.55 M(+12.1%) |
Sept 2023 | - | $5.84 M(+20.6%) |
June 2023 | - | $4.84 M(-17.8%) |
Mar 2023 | - | $5.89 M(-14.4%) |
Dec 2022 | $6.88 M(+101.1%) | $6.88 M(+17.1%) |
Sept 2022 | - | $5.88 M(-35.0%) |
June 2022 | - | $9.04 M(-25.5%) |
Mar 2022 | - | $12.13 M(+254.6%) |
Dec 2021 | $3.42 M | $3.42 M(-44.4%) |
Sept 2021 | - | $6.15 M(-13.9%) |
June 2021 | - | $7.14 M(+15.0%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $6.21 M(+78.1%) |
Dec 2020 | $3.49 M(+29.3%) | $3.49 M(-25.6%) |
Sept 2020 | - | $4.69 M(-30.6%) |
June 2020 | - | $6.76 M(-18.5%) |
Mar 2020 | - | $8.30 M(+207.5%) |
Dec 2019 | $2.70 M(+62.0%) | $2.70 M(+27.7%) |
Sept 2019 | - | $2.11 M(-21.9%) |
June 2019 | - | $2.71 M(+35.0%) |
Mar 2019 | - | $2.00 M(+20.3%) |
Dec 2018 | $1.67 M(+313.2%) | $1.67 M(+19.1%) |
Sept 2018 | - | $1.40 M(-46.3%) |
June 2018 | - | $2.60 M(+95.0%) |
Mar 2018 | - | $1.33 M(+231.3%) |
Dec 2017 | $403.00 K(+18.5%) | $403.00 K |
Dec 2016 | $340.00 K | - |
FAQ
- What is Crinetics Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly accounts payable year-on-year change?
What is Crinetics Pharmaceuticals annual accounts payable?
The current annual accounts payable of CRNX is $6.55 M
What is the all time high annual accounts payable for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual accounts payable is $6.88 M
What is Crinetics Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of CRNX is $4.94 M
What is the all time high quarterly accounts payable for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly accounts payable is $12.13 M
What is Crinetics Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, CRNX quarterly accounts payable has changed by -$1.61 M (-24.57%)